127 related articles for article (PubMed ID: 29943859)
1. Cutaneous manifestations in Egyptian children with beta-thalassemia major: Relationship with serum ferritin, thyroid profile, and treatment modalities.
El-Dash H; Adel S
Pediatr Dermatol; 2018 Sep; 35(5):639-643. PubMed ID: 29943859
[TBL] [Abstract][Full Text] [Related]
2. Skin Disorders in Egyptian Children with β-Thalassemia Major.
Fahmey SS; Taha G; El-Refaey A; Adly S
J Trop Pediatr; 2018 Apr; 64(2):104-109. PubMed ID: 28510704
[TBL] [Abstract][Full Text] [Related]
3. Skin diseases in patients with beta-thalassemia major.
Dogramaci AC; Savas N; Ozer B; Duran N
Int J Dermatol; 2009 Oct; 48(10):1057-61. PubMed ID: 19785086
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous Manifestations in Patients with Beta-Thalassemia Major.
Zulfiqar Z; Kanwal A; Chaudhry M; Aadil M; Qaiser S; Malik A; Abdullah M
J Mother Child; 2023 Jun; 27(1):142-146. PubMed ID: 37804540
[TBL] [Abstract][Full Text] [Related]
5. Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker.
Sherief LM; Dawood O; Ali A; Sherbiny HS; Kamal NM; Elshanshory M; Alazez OA; Alhady MA; Nour M; Mokhtar WA
BMC Pediatr; 2017 Mar; 17(1):69. PubMed ID: 28279156
[TBL] [Abstract][Full Text] [Related]
6. Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study.
Hagag AA; Elgamsy MA; El-Asy HM; Gamal RM; Elshahaby WN; Abd Elbar ES
Endocr Metab Immune Disord Drug Targets; 2016; 16(3):181-188. PubMed ID: 27829333
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy - deferasirox and deferoxamine - in thalassemia major patients in emerging countries with limited resources.
Arandi N; Haghpanah S; Safaei S; Zahedi Z; Ashrafi A; Eatemadfar P; Zarei T; Radwan AH; Taher AT; Karimi M
Transfus Med; 2015 Feb; 25(1):8-12. PubMed ID: 25801075
[TBL] [Abstract][Full Text] [Related]
8. Higher Serum Ferritin Levels Correlate with an Increased Risk of Cutaneous Morbidity in Adult Patients with β-Thalassemia: A Single-Center Retrospective Study.
Skandalis K; Vlachos C; Pliakou X; Gaitanis G; Kapsali E; Bassukas ID
Acta Haematol; 2016; 135(2):124-30. PubMed ID: 26509267
[TBL] [Abstract][Full Text] [Related]
9. Study of Serum Immunoglobulin Levels and T lymphocyte Subsets in Children with Beta Thalassemia with Iron Overload in Egypt.
Hagag AA; Elgamasy MA; Abd Elbar ES
Egypt J Immunol; 2016 Jan; 23(1):97-105. PubMed ID: 28502157
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
Daar S; Pathare AV
Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
[TBL] [Abstract][Full Text] [Related]
11. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
12. Comparison of deferiprone and deferrioxamine for the treatment of transfusional iron overload in children with beta thalassemia major.
Waheed N; Ali S; Butt MA
J Ayub Med Coll Abbottabad; 2014; 26(3):297-300. PubMed ID: 25671931
[TBL] [Abstract][Full Text] [Related]
13. [Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].
Cario H; Stahnke K; Kohne E
Klin Padiatr; 1999; 211(6):431-7. PubMed ID: 10592921
[TBL] [Abstract][Full Text] [Related]
14. [Curative effects and safety of deferasirox in treatment of iron overload in children with β-thalassemia major].
Gao HY; Li Q; Chen JJ; Chen GF; Li CG
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Jul; 13(7):531-4. PubMed ID: 21752315
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme Q10 levels in β-thalassemia and its association with ferritin levels and chelation therapy.
Karakukcu C; Karakukcu M; Unal E; Patiroglu T; Ozdemir MA; Torun YA; Tang PH
Hemoglobin; 2012; 36(3):219-29. PubMed ID: 22483337
[TBL] [Abstract][Full Text] [Related]
16. Assessment of thyroid function in two hundred patients with beta-thalassemia major.
Zervas A; Katopodi A; Protonotariou A; Livadas S; Karagiorga M; Politis C; Tolis G
Thyroid; 2002 Feb; 12(2):151-4. PubMed ID: 11916284
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular diastolic abnormalities in children with beta-thalassemia major: a Doppler echocardiographic study.
Yaprak I; Akşit S; Oztürk C; Bakiler AR; Dorak C; Türker M
Turk J Pediatr; 1998; 40(2):201-9. PubMed ID: 9677725
[TBL] [Abstract][Full Text] [Related]
18. Ocular abnormalities in multi-transfused beta-thalassemia patients.
Jafari R; Heydarian S; Karami H; Shektaei MM; Dailami KN; Amiri AA; Rezaee MR; Far AA
Indian J Ophthalmol; 2015 Sep; 63(9):710-5. PubMed ID: 26632126
[TBL] [Abstract][Full Text] [Related]
19. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience.
Abdelrazik N
Hematology; 2007 Dec; 12(6):577-85. PubMed ID: 17852442
[TBL] [Abstract][Full Text] [Related]
20. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
